Bruce Brockstein to Cost-Benefit Analysis
This is a "connection" page, showing publications Bruce Brockstein has written about Cost-Benefit Analysis.
Connection Strength
0.029
-
Measuring financial toxicity as a clinically relevant patient-reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST). Cancer. 2017 02 01; 123(3):476-484.
Score: 0.029